Tag: Aequus Pharmaceuticals

July 16, 2018

Aequus Extends and Enhances Commercial Agreement to Promote Vistitan in Canada

Aequus Pharmaceuticals (TSXV:AQS) has announced it has agreed to new terms for its promotional service agreement with Sandoz on Vistitan...
March 5, 2018

Aequus and Ehave Announce Collaboration Agreement for Patient Data

Aequus Pharmaceuticals and Ehave announced a new collaboration agreement with each other on the basis of Aequus using Ehave's bioinformatics...
January 31, 2018

Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch

Aequus Pharmaceuticals (TSXV: AQS) a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today announced plans to...
January 25, 2018

Aequus Announces Change to Proposed $300,000 Equity Financing

Aequus Pharmaceuticals (TSXV:AQS) a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, is pleased to...
November 16, 2017

Aequus To Receive European Patent for AQS1301

Aequus Pharmaceuticals announced the European Patent Office issued "an intention" to give the company a patent for AQS1301, Aequus' once-weekly...
October 10, 2017

Aequus Granted Chinese Patent for Once-Weekly Transdermal Aripiprazole

Aequus Pharmaceuticals (TSXV:AQS; OTCQB:AQSZF) has announced that the State Intellectual Property Office of the People’s Republic of China (SIPO) has...
August 30, 2017

Aequus Reports Q2 2017 Financials

Aequus Pharmaceuticals released their operational financial results for the second quarter of 2017.